Back to mobile site

Truist Securities Reiterates Hold Rating on AnaptysBio (ANAB)

November 19, 2024 2:45 PM EST Send to a Friend
Truist Securities analyst John Lee reiterated a Hold rating and $30.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst commented, "ANAB ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login